NPPB and cerebral cavernous malformation: Evaluating ECG markers, combined with echocardiography data, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and cardiac troponin biomarkers, leads to improved CCM diagnosis and risk stratification for liver transplant patients.